Testing effectiveness (Phase 2)Not Yet RecruitingNCT07825389What this trial is testingC-CAR168 in Participants With Progressive Multiple SclerosisWho this might be right forMultiple Sclerosis AbelZeta Inc. 119
Large-scale testing (Phase 3)Active Not RecruitingNCT05263934What this trial is testingEfficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA)Who this might be right forEosinophilic Granulomatosis With Polyangiitis GlaxoSmithKline 163
Early research (Phase 1)Not Yet RecruitingNCT07341828What this trial is testingC-CAR168 in the Treatment of Central Nervous System Autoimmune Diseases Refractory to Standard TherapyWho this might be right forMultiple Sclerosis (MS)Neuromyelitis Optica Spectrum Disorders (NMOSD)Autoimmune Encephalitis+1 more Huashan Hospital 15
Testing effectiveness (Phase 2)Study completedNCT02629419What this trial is testingCAMB/MAT2203 in Patients With Mucocutaneous CandidiasisWho this might be right forCandidiasis, Chronic Mucocutaneous Matinas BioPharma Nanotechnologies, Inc. 4
Testing effectiveness (Phase 2)Study completedNCT01274182What this trial is testingGP2013 in the Treatment of RA Patients Refractory to or Intolerant of Standard TherapyWho this might be right forRheumatoid Arthritis Sandoz 312
Early research (Phase 1)Looking for participantsNCT06249438What this trial is testingC-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard TherapyWho this might be right forSystemic Lupus Erythematosus (SLE)Immune-mediated Necrotizing Myopathy (IMNM)Neuromyelitis Optica Spectrum Disorders (NMOSD)+3 more RenJi Hospital 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07729826What this trial is testingC-CAR168 CAR T-Cell Therapy for the Treatment of Lupus Nephritis Refractory to Standard TherapyWho this might be right forLupus Nephritis (LN)Systemic Lupus Erythematosus (SLE)Autoimmune Diseases AbelZeta Inc. 50
Early research (Phase 1)Not Yet RecruitingNCT07676266What this trial is testingC-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard TherapyWho this might be right forMultiple Sclerosis (MS)Myasthenia Gravis (MG)Neuromyelitis Optica Spectrum Disorder+3 more The Affiliated Hospital of Qingdao University 18
Early research (Phase 1)Looking for participantsNCT07105735What this trial is testingRN1201 Injection for Autoimmune Diseases Refractory to Standard TherapiesWho this might be right forAutoimmune Diseases Refractory to Standard Therapies The First Affiliated Hospital with Nanjing Medical University 18
Testing effectiveness (Phase 2)WithdrawnNCT06935474What this trial is testingC-CAR168 CAR T Cell Therapy for Refractory Autoimmune DiseaseWho this might be right forLupus Nephritis (LN) AbelZeta Inc.